NCT01208064 2018-07-12Pazopanib Hydrochloride or a Placebo in Treating Patients With Non-Small Cell Lung Cancer Who Have Received First-Line ChemotherapyEuropean Organisation for Research and Treatment of Cancer - EORTCPhase 2/3 Terminated102 enrolled